Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.
Philip L R Gaskin, Stephen P H Alexander, Kevin C F Fone
Psychopharmacology June 2014 DOI: 10.1007/s00213-013-3424-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled experimental animal study Peer reviewed |
|---|---|
| Sample size | 42 |
| Population | Male Lister-hooded rat pups |
| Intervention | Phencyclidine (PCP) |
| Dose | 10 mg/kg PCP (s.c.) on postnatal days 7, 9, and 11; acute PCP challenge 3.2 mg/kg |
| Duration | Neonatal treatment on postnatal days 7, 9, and 11; behavioural testing six weeks post-weaning |
| Measures | novelty- and PCP-induced locomotor activity, novel object discrimination, prepulse inhibition of acoustic startle, contextual memory in a conditioned emotion response (CER) |
| Key findings | Neonatal PCP treatment and isolation rearing each produced behavioural deficits in adult rats, but the combination caused a wider range of more severe cognitive impairments, including greater reductions in conditioned fear freezing and prepulse inhibition deficits, which the authors propose makes it a more comprehensive preclinical model of schizophrenia than either challenge alone. |
Abstract
Schizophrenia is a debilitating disorder comprising positive, negative and cognitive deficits with a poorly defined neurobiological aetiology; therefore, animal models with greater translational reliability are essential to develop improved therapies. This study combines two developmental challenges in rats, neonatal phencyclidine (PCP) injection and subsequent rearing in social isolation from weaning, to attempt to produce more robust behavioural deficits with greater translational relevance to schizophrenia than either challenge alone. Forty-two male Lister-hooded rat pups received the N-methyl-D-aspartate (NMDA) receptor antagonist, phencyclidine (PCP, 10 mg/kg, s.c.), or vehicle on post-natal day (PND) 7, 9 and 11 and were weaned on PND 23 into group housing (saline-treated n = 11 or PCP-treated n = 10) or isolation (saline n = 10 or PCP n = 11). Six weeks post-weaning, novelty- and PCP-induced (3.2 mg/kg) locomotor activity, novel object discrimination, prepulse inhibition of acoustic startle and contextual memory in a conditioned emotion response (CER) were recorded. Isolation rearing alone significantly elevated baseline locomotor activity and induced visual recognition memory impairment in novel object discrimination. Neonatal PCP treatment did not induce locomotor sensitisation to a subsequent acute PCP injection, but it impaired prepulse inhibition when combined with isolation rearing. CER freezing behaviour was significantly reduced by isolation rearing but an even greater effect occurred when combined with neonatal PCP treatment. Neonatal PCP and isolation rearing both produce behavioural deficits in adult rats, but combined treatment caused a wider range of more severe cognitive impairments, providing a more comprehensive preclinical model to determine the neurobiological aetiology of schizophrenia than either treatment alone.
Citations in the library
Cited by 5
- GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia. Molecular Neurobiology September 1, 2024
- Effects of combined postweaning social isolation and ketamine administration on schizophrenia-like behaviour in male Sprague Dawley rats. Behavioural Brain Research January 5, 2025
- Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia. Molecular Neurobiology August 2020
- Impaired GAD1 expression in schizophrenia-related WISKET rat model with sex-dependent aggressive behavior and motivational deficit. Genes, brain, and behavior August 29, 2018
- Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia. The International Journal of Neuropsychopharmacology November 2016
Cites 8
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- NMDA receptor and schizophrenia: a brief history. Schizophrenia Bulletin September 2012
- The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Journal of Pharmacology and Experimental Therapeutics August 2011
- Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia. International Journal of Developmental Neuroscience May 2011
- Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine. Psychopharmacology February 1, 2011
and 3 more in the library